IMPACT OF SMOKING HISTORY ON THE REAL-WORLD EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITORS IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER: A NATIONWIDE POPULATION-BASED STUDY

被引：0
|
作者：
Lee, J. [1 ]
Kim, Y. [2 ,3 ]
Suh, H. S. [4 ]
机构：
[1] Kyung Hee Univ, Inst Regulatory Innovat Sci, Grad Sch, Dept Regulatory Sci, Seoul, South Korea
[2] Kyung Hee Univ, Inst Regulatory Innovat Sci IRIS, Coll Pharm, Seoul, South Korea
[3] Univ Texas Austin, Coll Pharm, Hlth Outcomes Div, Austin, TX USA
[4] Kyung Hee Univ, Inst Regulatory Innovat Sci, Coll Pharm, Dept Regulatory Sci,Grad Sch, Seoul, South Korea
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world effectiveness of pembrolizumab in previously treated non-small cell lung cancer: A population-based cohort study
    Murteira, Rodrigo
    Borges, Fabio Cardoso
    Mendes, Goncalo Pinto
    Ramos, Catarina
    Ramos, Adriana
    Soares, Patricia
    Furtado, Claudia
    Miranda, Ana
    da Costa, Filipa Alves
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1295 - 1302
  • [2] Influence of Smoking History on the Effectiveness of Immune-checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer: Analysis of Real-world Data
    Nakahama, Kenji
    Izumi, Motohiro
    Yoshimoto, Naoki
    Fukui, Mitsuru
    Sugimoto, Akira
    Nagamine, Hiroaki
    Ogawa, Koichi
    Sawa, Kenji
    Tani, Yoko
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Asai, Kazuhisa
    Kawaguchi, Tomoya
    ANTICANCER RESEARCH, 2023, 43 (05) : 2185 - 2197
  • [3] Immune Checkpoint Inhibitors in Real-World Treatment of Older Adults with Non-Small Cell Lung Cancer
    Muchnik, Eugene
    Loh, Kah Poh
    Strawderman, Myla
    Magnuson, Allison
    Mohile, Supriya G.
    Estrah, Vered
    Maggiore, Ronald J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 (05) : 905 - 912
  • [4] Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China
    Miao, Kang
    Zhang, Xiaotong
    Wang, Hanping
    Si, Xiaoyan
    Ni, Jun
    Zhong, Wei
    Zhao, Jing
    Xu, Yan
    Chen, Minjiang
    Pan, Ruili
    Wang, Mengzhao
    Zhang, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety
    Tang, Monica
    Lee, Chee
    Lewis, Craig
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 30 - 31
  • [6] Real-world effectiveness of immune checkpoint inhibitors alone or in combination with chemotherapy in metastatic non-small cell lung cancer.
    Hong, Lingzhi
    Rinsurongkawong, Waree
    Saad, Maliazurina B.
    Chen, Pingjun
    Aminu, Muhammad
    Spelman, Amy R.
    Negrao, Marcelo Vailati
    Cascone, Tina
    Lin, Steven H.
    Lee, Percy
    Sepesi, Boris
    Lewis, Jeff
    Gibbons, Don Lynn
    Vaporciyan, Ara A.
    Lee, J. Jack
    Le, Xiuning
    Wu, Jia
    Heymach, John
    Zhang, Jianjun
    Vokes, Natalie I.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Real-World Data in Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors in a Latin American Institution
    Paytan, T.
    Ruiz, R.
    Araujo, J.
    Juarez, D.
    Gutierrez, J. M.
    Morante, Z.
    Aguilar, A.
    Mas, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S300 - S300
  • [8] Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study
    Calleja-Chucla, Teresa
    Gonzalez, Patricia Cordeiro
    Pradeda, Alejandro Martinez
    Pertega-Diaz, Sonia
    Margusino-Framinan, Luis
    Novoa, Silvia Antolin
    BIOMEDICINES, 2025, 13 (02)
  • [9] Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
    Cunha, R.
    Fernandes, M.
    Abreu, S.
    Oliveira, C.
    Dias, J.
    Alves, S.
    Rodrigues, A.
    Oliveira, J.
    Pousa, M. I.
    Soares, M.
    Azevedo, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [10] Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting
    Rizzo, Manglio Miguel
    Bluthgen, Maria Virginia
    Recondo, Gonzalo
    Naveira, Martin
    Perfetti, Aldo
    Rizzi, Florencia
    Kuzminin, Alejandro
    Faura, Victoria
    Cerini, Matias
    Videla, Alejandro
    Silva, Carlos
    Lupinacci, Lorena
    Minatta, Nicolas
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (06) : 1057 - 1064
12345